DOI : 10.1055/s-00000034

Klinische Pädiatrie

Issue 06 · Volume 230 · October 2018 DOI: 10.1055/s-008-41711

Working group “Experimental Neuro-Oncology”
27th Annual Meeting of the working group “Experimental Neuro-Oncology”
University Hospital for Children and Adolescents, Johannes Wesling Klinikum Minden, Ruhr University Bochum, Germany, 27.–28.04.2018

Chair: Bernhard Erdlenbruch, Minden
Abstracts (HTML) List of Authors
E
Erdlenbruch, B: Editorial
1
Kattner, P; Nonnenmacher, L; Buljovcic, K; Bartholomä, S; Zeiler, K; Karpel-Massler, G; Halatsch, ME; Westhoff, MA; Debatin, KM: Combination therapy as a potential strategy in Glioblastoma treatment
2
Classen, CF; Gutmann, F: Malignancy-promoting EGFR overexpression in glioblastoma: in vitro inhibitor susceptibility and establishment of an in vivo model
3
Patties, I; Thöle, L; Gaunitz, F; Kortmann, RD; Glasow, A: Treatment of human glioblastoma cells with the Chk1 inhibitor SAR-020106 and irradiation and/or 5-aza-2'deoxycytidine synergistically reduces clonogenic survival
4
Hlavac, M; Dwucet, A; Westhoff, A; Kast, RE; Engelke, J; Siegelin, MD; Wirtz, CR; Halatsch, ME; Karpel-Massler, G: Combined Bcl-2/Bcl-xL and RAC1 inhibition yields a synergistic antineoplastic activity in glioblastoma
5
Kim, EL: Integrated approach to delineating molecular traits of recurrent glioblastoma using glioma stem cell models and tumor tissue profiling
6
Marcu, A; Trautwein, N; Stevanovic, S; Johann, P; Technau, A; Lager, J; Monoranu, C; Henkel, L; Krauß, J; Ebinger, M; Schuhmann, M; Thomale, U; Pietsch, T; Wölfl, M; Schlegel, PG; Frühwald, M; Oyen, F; Reisner, Y; Rammensee, HG; Eyrich, M: Deciphering the AT/RT ligandome
7
Van Gool, SW; Makalowski, J; Feyen, O; Machova, A; Schierl, R; Schirrmacher, V; Stuecker, W: Tumor epitope detection in monocytes (EDIM) as a marker for antitumoral activity of Newcastle disease virus infusion and modulated electrohyperthermia
8
Van Gool, SW; Makalowski, J; Feyen, O; Fiedler, L; Prix, L; Schirrmacher, V; Stuecker, W: Multimodal immunotherapy integrated into standard therapy for GBM: learning from clinical practice
9
Deng, MY; Sturm, D; Pfaff, E; Balasubrama, GP; Schittenhelm, J; Ebinger, M; Schuhmann, M; Korshunov, A; Deimling, A von; Witt, O; Pfister, SM; Jones, DTW: Molecular Characterization of Radiation-induced Glioblastoma
10
Halatsch, ME; Kast, RE; Westhoff, A; Dwucet, A; Hlavac, M; Siegelin, MD; Wirtz, CR; Karpel-Massler, G: BH-3 mimetics combined with CUSP9 – Multi-targeting meets repurposing